Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells

被引:70
作者
Abedini, Mohammad R. [4 ,5 ]
Muller, Emilie J. [2 ,5 ]
Brun, Jan [3 ,9 ]
Bergeron, Richard [2 ,5 ,8 ]
Gray, Douglas A. [3 ,7 ,9 ]
Tsang, Benjamin K. [1 ,5 ,6 ]
机构
[1] Ottawa Hlth Res Inst, Dept Chron Dis, Ottawa, ON K1Y 4E9, Canada
[2] Ottawa Hlth Res Inst, Dept Neurosci, Ottawa, ON K1Y 4E9, Canada
[3] Ottawa Hlth Res Inst, Canc Therapeut Programs, Ottawa, ON K1Y 4E9, Canada
[4] Birjand Univ Med Sci, Dept Phys & Pharmacol, Birjand, Iran
[5] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada
[6] Univ Ottawa, Dept Obstet & Gynaecol, Ottawa, ON K1N 6N5, Canada
[7] Univ Ottawa, Dept Med, Ottawa, ON K1N 6N5, Canada
[8] Univ Ottawa, Dept Psychiat, Ottawa, ON K1N 6N5, Canada
[9] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1N 6N5, Canada
关键词
D O I
10.1158/0008-5472.CAN-08-0673
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Understanding the mechanism of cisplatin (CDDP) action may improve therapeutic strategy for ovarian cancer. Although p53 and FLICE-like inhibitory protein (FLIP) are determinants of CDDP sensitivity in ovarian cancer, the interaction between p53 and FLIP remains poorly understood. Here, using two chemosensitive ovarian cancer cell lines and various molecular and cellular approaches, we show that CDDP induces p53-dependent FLIP ubiquitination and degradation, and apoptosis in vitro. Moreover, we showed that Itch (an E3 ligase) forms a complex with FLIP and p53 upon CDDP treatment. These results suggest that p53 facilitates FLIP down-regulation by CDDP-induced FLIP ubiquitination and proteasomal degradation.
引用
收藏
页码:4511 / 4517
页数:7
相关论文
共 20 条
[1]   Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro [J].
Abedini, MR ;
Qiu, Q ;
Yan, XJ ;
Tsang, BK .
ONCOGENE, 2004, 23 (42) :6997-7004
[2]   Role of the Cldn6 cytoplasmic tail domain in membrane targeting and epidermal differentiation in vivo [J].
Arabzadeh, Azadeh ;
Troy, Tammy-Claire ;
Turksen, Kursad .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (15) :5876-5887
[3]   Influence of TRP53 status on FAS membrane localization, CFLAR (c-FLIP) ubiquitinylation, and sensitivity of CC-2spd (ts) cells to undergo FAS-mediated apoptosis [J].
Chandrasekaran, Y ;
Mckee, CA ;
Ye, Y ;
Richburg, JH .
BIOLOGY OF REPRODUCTION, 2006, 74 (03) :560-568
[4]   The E3 ubiquitin ligase itch couples JNK activation to TNFα-induced cell death by inducing c-FLIPL turnover [J].
Chang, LF ;
Kamata, H ;
Solinas, G ;
Luo, JL ;
Maeda, S ;
Venuprasad, K ;
Liu, YC ;
Karin, M .
CELL, 2006, 124 (03) :601-613
[5]   CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and Ubiquitin/Proteasome- mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non-small-cell lung cancer cells [J].
Chen, Shuzhen ;
Liu, Xiangguo ;
Yue, Ping ;
Schoenthal, Axel H. ;
Khuri, Fadlo R. ;
Sun, Shi-Yong .
MOLECULAR PHARMACOLOGY, 2007, 72 (05) :1269-1279
[6]   Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway [J].
Cheng, JQ ;
Jiang, XX ;
Fraser, M ;
Li, M ;
Dan, HC ;
Sun, M ;
Tsang, BK .
DRUG RESISTANCE UPDATES, 2002, 5 (3-4) :131-146
[7]   RETRACTED: Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP) (Retracted Article) [J].
Dan, HC ;
Sun, M ;
Kaneko, S ;
Feldman, RI ;
Nicosia, SV ;
Wang, HG ;
Tsang, BK ;
Cheng, JQ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (07) :5405-5412
[8]  
Fraser M, 2003, CANCER RES, V63, P7081
[9]   Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function [J].
Fraser, Michael ;
Bai, Tao ;
Tsang, Benjamin K. .
INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (03) :534-546
[10]   Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells [J].
Fukazawa, T ;
Fujiwara, T ;
Uno, F ;
Teraishi, F ;
Kadowaki, Y ;
Itoshima, T ;
Takata, Y ;
Kagawa, S ;
Roth, JA ;
Tschopp, J ;
Tanaka, N .
ONCOGENE, 2001, 20 (37) :5225-5231